FLAT Prices Act

Summary

Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 6 February 2019

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)

   Source: IntroReferral

2. 6 February 2019

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 6 February 2019 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 6 February 2019

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 6 February 2019

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 6 February 2019

  Open at official source

Sponsors

• Richard Durbin · D · Sponsor
• Sen. Harris, Kamala D. [D-CA] · D · Sponsor
• Tina Smith · D · Sponsor
• Amy Klobuchar · D · Sponsor
• Richard Blumenthal · D · Sponsor
• Sen. Brown, Sherrod [D-OH] · D · Cosponsor
• Gary Peters · D · Cosponsor
• · sshr00 · Standing

Related records

• related to ← FLAT Prices Act